Vasopressin compared with norepinephrine augments the decline of plasma cytokine levels in septic shock

James A. Russell, Chris Fjell, Joseph L. Hsu, Terry Lee, John Boyd, Simone Thair, Joel Singer, Andrew J. Patterson, Keith R. Walley

Research output: Contribution to journalArticle

48 Citations (Scopus)

Abstract

Rationale: Changes in plasma cytokine levels may predict mortality, and therapies (vasopressin versus norepinephrine) could change plasma cytokine levels in early septic shock. Objectives: Our hypotheses were that changes in plasma cytokine levels over 24 hours differ between survivors and nonsurvivors, and that there are different effects of vasopressin and norepinephrine on plasma cytokine levels in septic shock. Methods:We studied 394 patients in a randomized, controlled trial of vasopressin versus norepinephrine in septic shock. We used hierarchical clustering and principal components analysis of the baseline cytokine concentrations to subgroup cytokines; we then compared survivors to nonsurvivors (28 d) and compared vasopressin- versus norepinephrine-induced changes in cytokine levels over 24 hours. Measurements and Main Results: A total of 39 plasma cytokines were measured at baseline and at 24 hours. Hierarchical clustering and principal components analysis grouped cytokines similarly. Survivors (versus nonsurvivors) had greater decreases of overall cytokine levels (P , 0.001). Vasopressin decreased overall 24-hour cytokine concentration compared with norepinephrine (P = 0.037). In less severe septic shock, the difference in plasma cytokine reduction over 24 hours between survivors and nonsurvivors was less pronounced than that seen inmoresevere septic shock. Furthermore, vasopressin decreased interferon-inducible protein 10 and granulocyte colony- stimulating factormore than did norepinephrine in less severe septic shock, whereas vasopressin decreased granulocyte-macrophage colony-stimulating factor in patients who had more severe shock. Conclusions: Survivors of septic shock had greater decreases of cytokines, chemokines and growth factors in early septic shock. Vasopressin decreased 24-hour plasma cytokine levels more than did norepinephrine. The vasopressin-associated decrease of cytokines differed according to severity of shock. Clinical trial registeredwithwww.controlled-trials.com (ISRCTN94845869).

Original languageEnglish (US)
Pages (from-to)356-364
Number of pages9
JournalAmerican Journal of Respiratory and Critical Care Medicine
Volume188
Issue number3
DOIs
StatePublished - Aug 1 2013

Fingerprint

Septic Shock
Vasopressins
Norepinephrine
Cytokines
Survivors
Principal Component Analysis
Cluster Analysis
Shock
Chemokine CXCL10
Granulocyte-Macrophage Colony-Stimulating Factor
Chemokines
Granulocytes
Intercellular Signaling Peptides and Proteins
Randomized Controlled Trials

Keywords

  • Chemokines
  • Cytokines
  • Norepinephrine
  • Septic shock
  • Vasopressin

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine

Cite this

Vasopressin compared with norepinephrine augments the decline of plasma cytokine levels in septic shock. / Russell, James A.; Fjell, Chris; Hsu, Joseph L.; Lee, Terry; Boyd, John; Thair, Simone; Singer, Joel; Patterson, Andrew J.; Walley, Keith R.

In: American Journal of Respiratory and Critical Care Medicine, Vol. 188, No. 3, 01.08.2013, p. 356-364.

Research output: Contribution to journalArticle

Russell, JA, Fjell, C, Hsu, JL, Lee, T, Boyd, J, Thair, S, Singer, J, Patterson, AJ & Walley, KR 2013, 'Vasopressin compared with norepinephrine augments the decline of plasma cytokine levels in septic shock', American Journal of Respiratory and Critical Care Medicine, vol. 188, no. 3, pp. 356-364. https://doi.org/10.1164/rccm.201302-0355OC
Russell, James A. ; Fjell, Chris ; Hsu, Joseph L. ; Lee, Terry ; Boyd, John ; Thair, Simone ; Singer, Joel ; Patterson, Andrew J. ; Walley, Keith R. / Vasopressin compared with norepinephrine augments the decline of plasma cytokine levels in septic shock. In: American Journal of Respiratory and Critical Care Medicine. 2013 ; Vol. 188, No. 3. pp. 356-364.
@article{82ab0408eece429b8b2249ba54413694,
title = "Vasopressin compared with norepinephrine augments the decline of plasma cytokine levels in septic shock",
abstract = "Rationale: Changes in plasma cytokine levels may predict mortality, and therapies (vasopressin versus norepinephrine) could change plasma cytokine levels in early septic shock. Objectives: Our hypotheses were that changes in plasma cytokine levels over 24 hours differ between survivors and nonsurvivors, and that there are different effects of vasopressin and norepinephrine on plasma cytokine levels in septic shock. Methods:We studied 394 patients in a randomized, controlled trial of vasopressin versus norepinephrine in septic shock. We used hierarchical clustering and principal components analysis of the baseline cytokine concentrations to subgroup cytokines; we then compared survivors to nonsurvivors (28 d) and compared vasopressin- versus norepinephrine-induced changes in cytokine levels over 24 hours. Measurements and Main Results: A total of 39 plasma cytokines were measured at baseline and at 24 hours. Hierarchical clustering and principal components analysis grouped cytokines similarly. Survivors (versus nonsurvivors) had greater decreases of overall cytokine levels (P , 0.001). Vasopressin decreased overall 24-hour cytokine concentration compared with norepinephrine (P = 0.037). In less severe septic shock, the difference in plasma cytokine reduction over 24 hours between survivors and nonsurvivors was less pronounced than that seen inmoresevere septic shock. Furthermore, vasopressin decreased interferon-inducible protein 10 and granulocyte colony- stimulating factormore than did norepinephrine in less severe septic shock, whereas vasopressin decreased granulocyte-macrophage colony-stimulating factor in patients who had more severe shock. Conclusions: Survivors of septic shock had greater decreases of cytokines, chemokines and growth factors in early septic shock. Vasopressin decreased 24-hour plasma cytokine levels more than did norepinephrine. The vasopressin-associated decrease of cytokines differed according to severity of shock. Clinical trial registeredwithwww.controlled-trials.com (ISRCTN94845869).",
keywords = "Chemokines, Cytokines, Norepinephrine, Septic shock, Vasopressin",
author = "Russell, {James A.} and Chris Fjell and Hsu, {Joseph L.} and Terry Lee and John Boyd and Simone Thair and Joel Singer and Patterson, {Andrew J.} and Walley, {Keith R.}",
year = "2013",
month = "8",
day = "1",
doi = "10.1164/rccm.201302-0355OC",
language = "English (US)",
volume = "188",
pages = "356--364",
journal = "American Journal of Respiratory and Critical Care Medicine",
issn = "1073-449X",
publisher = "American Thoracic Society",
number = "3",

}

TY - JOUR

T1 - Vasopressin compared with norepinephrine augments the decline of plasma cytokine levels in septic shock

AU - Russell, James A.

AU - Fjell, Chris

AU - Hsu, Joseph L.

AU - Lee, Terry

AU - Boyd, John

AU - Thair, Simone

AU - Singer, Joel

AU - Patterson, Andrew J.

AU - Walley, Keith R.

PY - 2013/8/1

Y1 - 2013/8/1

N2 - Rationale: Changes in plasma cytokine levels may predict mortality, and therapies (vasopressin versus norepinephrine) could change plasma cytokine levels in early septic shock. Objectives: Our hypotheses were that changes in plasma cytokine levels over 24 hours differ between survivors and nonsurvivors, and that there are different effects of vasopressin and norepinephrine on plasma cytokine levels in septic shock. Methods:We studied 394 patients in a randomized, controlled trial of vasopressin versus norepinephrine in septic shock. We used hierarchical clustering and principal components analysis of the baseline cytokine concentrations to subgroup cytokines; we then compared survivors to nonsurvivors (28 d) and compared vasopressin- versus norepinephrine-induced changes in cytokine levels over 24 hours. Measurements and Main Results: A total of 39 plasma cytokines were measured at baseline and at 24 hours. Hierarchical clustering and principal components analysis grouped cytokines similarly. Survivors (versus nonsurvivors) had greater decreases of overall cytokine levels (P , 0.001). Vasopressin decreased overall 24-hour cytokine concentration compared with norepinephrine (P = 0.037). In less severe septic shock, the difference in plasma cytokine reduction over 24 hours between survivors and nonsurvivors was less pronounced than that seen inmoresevere septic shock. Furthermore, vasopressin decreased interferon-inducible protein 10 and granulocyte colony- stimulating factormore than did norepinephrine in less severe septic shock, whereas vasopressin decreased granulocyte-macrophage colony-stimulating factor in patients who had more severe shock. Conclusions: Survivors of septic shock had greater decreases of cytokines, chemokines and growth factors in early septic shock. Vasopressin decreased 24-hour plasma cytokine levels more than did norepinephrine. The vasopressin-associated decrease of cytokines differed according to severity of shock. Clinical trial registeredwithwww.controlled-trials.com (ISRCTN94845869).

AB - Rationale: Changes in plasma cytokine levels may predict mortality, and therapies (vasopressin versus norepinephrine) could change plasma cytokine levels in early septic shock. Objectives: Our hypotheses were that changes in plasma cytokine levels over 24 hours differ between survivors and nonsurvivors, and that there are different effects of vasopressin and norepinephrine on plasma cytokine levels in septic shock. Methods:We studied 394 patients in a randomized, controlled trial of vasopressin versus norepinephrine in septic shock. We used hierarchical clustering and principal components analysis of the baseline cytokine concentrations to subgroup cytokines; we then compared survivors to nonsurvivors (28 d) and compared vasopressin- versus norepinephrine-induced changes in cytokine levels over 24 hours. Measurements and Main Results: A total of 39 plasma cytokines were measured at baseline and at 24 hours. Hierarchical clustering and principal components analysis grouped cytokines similarly. Survivors (versus nonsurvivors) had greater decreases of overall cytokine levels (P , 0.001). Vasopressin decreased overall 24-hour cytokine concentration compared with norepinephrine (P = 0.037). In less severe septic shock, the difference in plasma cytokine reduction over 24 hours between survivors and nonsurvivors was less pronounced than that seen inmoresevere septic shock. Furthermore, vasopressin decreased interferon-inducible protein 10 and granulocyte colony- stimulating factormore than did norepinephrine in less severe septic shock, whereas vasopressin decreased granulocyte-macrophage colony-stimulating factor in patients who had more severe shock. Conclusions: Survivors of septic shock had greater decreases of cytokines, chemokines and growth factors in early septic shock. Vasopressin decreased 24-hour plasma cytokine levels more than did norepinephrine. The vasopressin-associated decrease of cytokines differed according to severity of shock. Clinical trial registeredwithwww.controlled-trials.com (ISRCTN94845869).

KW - Chemokines

KW - Cytokines

KW - Norepinephrine

KW - Septic shock

KW - Vasopressin

UR - http://www.scopus.com/inward/record.url?scp=84881173520&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84881173520&partnerID=8YFLogxK

U2 - 10.1164/rccm.201302-0355OC

DO - 10.1164/rccm.201302-0355OC

M3 - Article

C2 - 23796235

AN - SCOPUS:84881173520

VL - 188

SP - 356

EP - 364

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

SN - 1073-449X

IS - 3

ER -